Recruiting NA Diabetic Polyneuropathy

New treatment option for Diabetic Polyneuropathy

Official title Combined Effects of Foot-Ankle Therapeutic Exercises and Mindful Walking in Patients With Diabetic Polyneuropathy

ClinicalTrials.gov ID: NCT07248631

What this study is testing

What it's testing
The aim of this study is to investigate the combined effects of foot ankle therapeutic exercises and mindful walking on pain, foot and ankle disability, and quality of life in patients with diabetic polyneuropathy. This study seeks to evaluate the efficacy of these interventions in improving clinical outcomes and enhancing the overall well-being of individuals with diabetic polyneuropathy.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 40 to 75

You may be able to join if

  • Diagnosed with diabetic polyneuropathy (DPN) confirmed by medical history and clinical examination.
  • Experience pain and disability in foot/ankle, with a Numeric Pain Rating Scale (NPRS) score ≥ 4.
  • Independent walking ability for at least 10 m.
  • Age (40-75) years.
  • Ability to understand and follow exercise instructions.

You likely can't join if

  • Presence of an active plantar ulcer or gangrene.
  • History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period.
  • Arthroplasty and/or orthosis of lower limbs or indication of lower limb arthroplasty throughout the intervention period.
  • Participating in other exercise programs or studies.
  • Dementia or inability to give consistent information.
  • Diagnosis of neurological diseases.
See the full eligibility criteria
Who can join
  • Diagnosed with diabetic polyneuropathy (DPN) confirmed by medical history and clinical examination.
  • Experience pain and disability in foot/ankle, with a Numeric Pain Rating Scale (NPRS) score ≥ 4.
  • Independent walking ability for at least 10 m.
  • Age (40-75) years.
  • Ability to understand and follow exercise instructions.
  • A maximum of one amputated toe, not being the hallux.
  • Willingness to participate in the study and provide informed consent.
What rules you out
  • Presence of an active plantar ulcer or gangrene.
  • History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period.
  • Arthroplasty and/or orthosis of lower limbs or indication of lower limb arthroplasty throughout the intervention period.
  • Participating in other exercise programs or studies.
  • Dementia or inability to give consistent information.
  • Diagnosis of neurological diseases.
  • Neuropathic pain due to other causes (e.g., HIV, chemotherapy).
  • Major vascular complications and/or severe retinopathy.

The study team makes the final eligibility decision.

Where it's taking place

  • Multan, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 40 months to 75 months. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Multan, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.